Market News
India hemostat market: Key Developments
- , a startup based in Bengaluru, India, received US$ 5.2 Mn in funding in January 2020 to expand into international markets, led by Omidyar Network India-a philanthropic investment firm. Using cutting-edge biomaterial-based technology, the startup creates exclusive medical products for the Indian and global hemostatic and advanced wound care market. The business has raised US$ 6 Mn in funding in 2023, led by TrueScale Capital.
- In March 2020, , a subsidiary of Johnson & Johnson Medical Devices Companies, announced the regional launch of SURGICEL POWDER ABSORBABLE HEMOSTAT in India.